Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
A company introduction movie for SAMICK THK CO., LTD., part of the Korean SAMICK THK Group.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ju-Wan Jin is President/Co-CEO at Samick Thk Co Ltd.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Lepidico: Innovating Lithium Extraction from Non-Traditional Sources
00:10:00
Revolutionizing Drug Delivery: Medesis Pharma's Breakthrough with Aonys Technology | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
Inside Taiwan's Cutting-Edge Semiconductor Mega Factories|C.C Wei,CEO,TSMC
00:10:00
Colonial Coal (CAD) - Sales Process Started as Met Coal Prices Excite | David Austin, CEO, Colonial Coal International CorpCAD:CVE
00:10:00
First Mining Gold: Advancing Canadian Projects and Broadening Investor Base at One-to-One Conference
00:10:00
Verdant Minerals: Navigating Towards Production and Expansion at One-to-One Mining Conference
00:10:00
Weathering Controversy and Forging Ahead in Finance | Michael Rees , co-founder , Blue Owl Capital .
00:00:00
Wesley Wong Associate Professor of Biological Chemistry and Molecular Pharmacology, HMS
00:10:00
Navigating the Diamond Industry's Challenges: Insights from Firestone Diamonds
00:10:00
Delivering Predictable Distributions and Sustainable Growth: The Arena REIT Approach to Social Infrastructure Investment|CEO , Arena Reit No 1
00:10:00
Investing in India's Growth Story: Insights from Amar Kalkundrikar of Nippon India Mutual Fund | Amar Kalkundrikar - Fund Manager, Nippon India Mutual Fund
00:10:00
Invests in the blockchain space to advance the adoption of cryptocurrency|Niraj Pant,General Partner,Polychain